Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Innovative Healthcare Ishares Evolved ETF (IEIH)

US Innovative Healthcare Ishares Evolved ETF (IEIH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 38,643,000
  • Shares Outstanding, K 1,100
  • 60-Month Beta 0.71
Trade IEIH with:
  • Price/Earnings ttm 28.91
  • Annual Dividend & Yield 1.01 (2.90%)
  • Most Recent Dividend 0.086 on 06/10/21
  • Management Fee 0.18%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.28 +7.75%
on 05/12/21
35.17 -1.10%
on 06/10/21
+2.25 (+6.92%)
since 05/11/21
3-Month
31.33 +11.02%
on 03/25/21
35.17 -1.10%
on 06/10/21
+2.07 (+6.34%)
since 03/11/21
52-Week
27.81 +25.07%
on 06/15/20
35.17 -1.10%
on 06/10/21
+6.53 (+23.10%)
since 06/11/20

Most Recent Stories

More News
Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results

Johnson & Johnson (JNJ) continued its long streak of earnings beat and outpaced revenue estimates. However, the company tightened its full-year guidance.

JNJ : 164.96 (-1.27%)
XLV : 124.55 (-0.71%)
VHT : 244.04 (-0.50%)
IYH : 268.83 (-0.76%)
IHE : 187.83 (-0.92%)
IEIH : 34.78 (-0.96%)
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 164.96 (-1.27%)
XLV : 124.55 (-0.71%)
IYH : 268.83 (-0.76%)
IHE : 187.83 (-0.92%)
FTXH : 26.31 (-0.49%)
IEIH : 34.78 (-0.96%)
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

PFE : 40.15 (-1.30%)
MRNA : 218.85 (+0.85%)
IHE : 187.83 (-0.92%)
FDL : 34.59 (+0.14%)
FTXH : 26.31 (-0.49%)
IEIH : 34.78 (-0.96%)
BNTX : 238.55 (-0.53%)
ETFs to Tap Amgen's Drive for Cancer Deal

Amgen (AMGN) has agreed to buy Five Prime Therapeutics (FPRX) for $1.9 billion.

BMY : 67.34 (-0.07%)
AMGN : 242.77 (-0.76%)
IBB : 162.11 (-0.67%)
FPRX : 38.00 (+0.03%)
BBH : 198.70 (-1.09%)
PJP : 81.55 (-0.65%)
IEIH : 34.78 (-0.96%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 164.96 (-1.27%)
XLV : 124.55 (-0.71%)
IYH : 268.83 (-0.76%)
IHE : 187.83 (-0.92%)
FTXH : 26.31 (-0.49%)
IEIH : 34.78 (-0.96%)
JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus

The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.

JNJ : 164.96 (-1.27%)
PFE : 40.15 (-1.30%)
MRNA : 218.85 (+0.85%)
XLV : 124.55 (-0.71%)
VHT : 244.04 (-0.50%)
IYH : 268.83 (-0.76%)
IHE : 187.83 (-0.92%)
IEIH : 34.78 (-0.96%)
ETFs to Shine as Pfizer's COVID-19 Vaccine Gets a Nod in Europe

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

DHS : 80.76 (+0.06%)
FDL : 34.59 (+0.14%)
HDV : 98.33 (-0.18%)
FTXH : 26.31 (-0.49%)
IEIH : 34.78 (-0.96%)
Pfizer's Coronavirus Vaccine Gets a Nod in UK: ETFs to Shine

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

PFE : 40.15 (-1.30%)
DHS : 80.76 (+0.06%)
FDL : 34.59 (+0.14%)
HDV : 98.33 (-0.18%)
FTXH : 26.31 (-0.49%)
IEIH : 34.78 (-0.96%)
What Lies Ahead for Pfizer ETFs After Another Round of Upbeat Vaccine Data

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in the coronavirus vaccine development.

DHS : 80.76 (+0.06%)
FDL : 34.59 (+0.14%)
HDV : 98.33 (-0.18%)
FTXH : 26.31 (-0.49%)
IEIH : 34.78 (-0.96%)
J&J Pauses Coronavirus Vaccine Trial: ETFs That May Take a Hit

Johnson & Johnson's pausing of dosing in all clinical studies on its coronavirus vaccine candidate has increased uncertainty surrounding the coronavirus vaccine development.

XLV : 124.55 (-0.71%)
VHT : 244.04 (-0.50%)
IYH : 268.83 (-0.76%)
IHE : 187.83 (-0.92%)
IEIH : 34.78 (-0.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Fund Summary

The iShares Evolved U.S. Innovative Healthcare ETF seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system.

See More

Top 10 Holdings

Name % Holdings
Johnson & Johnson 9.57%
Pfizer Inc 6.03%
AbbVie Inc 5.84%
ELI LILLY 5.73%
MERCK & CO 5.55%
Moderna Inc 4.91%
Bristol-Myers Squibb Co 4.60%
GILEAD SCI 4.46%
AMGEN INC 4.11%
BIOGEN INC 3.47%

See More

Key Turning Points

3rd Resistance Point 35.52
2nd Resistance Point 35.29
1st Resistance Point 35.03
Last Price 34.78
1st Support Level 34.55
2nd Support Level 34.31
3rd Support Level 34.06

See More

52-Week High 35.17
Last Price 34.78
Fibonacci 61.8% 32.36
Fibonacci 50% 31.49
Fibonacci 38.2% 30.62
52-Week Low 27.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar